In a very interesting paper, Dutch pharmaceutical company NeuroSearch, in conjunction with Canadian research corporation Kendle Early Stage, report on Subjective and Objective Effects of the Novel Triple Reuptake Inhibitor Tesofensine in Recreational Stimulant Users.
It's Like Cocaine, But No Fun
New study puts Tesofensine, or tes-fens, to the test.
Newsletter
Sign up for our email newsletter for the latest science news
0 free articles left
Want More? Get unlimited access for as low as $1.99/month
Stay Curious
Sign up for our weekly newsletter and unlock one more article for free.
View our Privacy Policy
Want more?
Keep reading for as low as $1.99!
Already a subscriber?
Find my Subscription
More From Discover
Recommendations From Our Store
Stay Curious
Subscribe
To The Magazine
Save up to 40% off the cover price when you subscribe to Discover magazine.
Copyright © 2024 Kalmbach Media Co.